Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer

Ayca Gucalp, Joseph A. Sparano, James Caravelli, Jean Santamauro, Sujata Patil, Alyson Abbruzzi, Christine Pellegrino, Jackie Bromberg, Chau Dang, Maria Theodoulou, Joan Massague, Larry Norton, Clifford Hudis, Tiffany A. Traina

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences